Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($0.23), $2.70 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $2.82 million versus the consensus estimate of $3.08 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.